Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

TY-4028

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

TYK Medicines

Drug class:

HER2 exon 20 inhib

Related drugs:

‹

›

EGFR exon 20 insertion	Non Small Cell Lung Cancer	EGFR exon 20 insertion	Non Small Cell Lung Cancer	TY-4028 Sensitive: D – Preclinical AACR 2023 - 1 week (New D) TY-4028 Sensitive : D AACR 2023 - 1wk	TY-4028 Sensitive: D – Preclinical AACR 2023 - 1 week TY-4028 Sensitive : D AACR 2023 - 1 week - (New D)
HER-2 exon 20 insertion	Non Small Cell Lung Cancer	HER-2 exon 20 insertion	Non Small Cell Lung Cancer	TY-4028 Sensitive: D – Preclinical AACR 2023 - 1 week (New D) TY-4028 Sensitive : D AACR 2023 - 1wk	TY-4028 Sensitive: D – Preclinical AACR 2023 - 1 week TY-4028 Sensitive : D AACR 2023 - 1 week - (New D)